Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus

被引:78
|
作者
Lewis, Jason J. [1 ]
Rubenstein, Joel H. [2 ]
Singal, Amit G. [1 ]
Elmunzer, B. Joseph [1 ]
Kwon, Richard S. [1 ]
Piraka, Cyrus R. [1 ]
机构
[1] Univ Michigan Hlth Syst, Div Gastroenterol, Ann Arbor, MI USA
[2] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA
关键词
HIGH-GRADE DYSPLASIA; PHOTODYNAMIC THERAPY; SURVEILLANCE; VALIDATION; PREDICTORS; ABLATION;
D O I
10.1016/j.gie.2011.05.031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: EMR for early neoplastic Barrett's esophagus is gaining favor over esophagectomy. Esophageal stricture development has been reported as a common complication of EMR, photodynamic therapy, and combination endoscopic therapy. Objective: To determine clinical and procedural predictors of symptomatic stricture formation after EMR. Design: Retrospective analysis. Setting: Tertiary-care referral university hospital. Patients: Data were retrospectively reviewed on 73 patients at our institution who underwent EMR monotherapy for Barrett's esophagus with high-grade dysplasia or intramucosal cancer since January 2006. Intervention: EMR. Main Outcome Measurements: Symptomatic esophageal stricture formation. Results: Symptomatic esophageal stricture formation was noted in 24.7% of patients undergoing EMR. Stricture formation on univariate analysis was associated with percentage of circumference of esophageal lumen resected, total pieces resected, number of EMR sessions, and tobacco use. A threshold effect was found at 50% of esophageal circumference resected (66.7% vs 27.2% developed strictures above and below the threshold, respectively; P = .004). A 25-pack-year or greater history of tobacco use had a threshold effect on esophageal stricture formation (77.8% vs 7.2% developed strictures above and below the threshold, respectively; P = .02). In multivariate analysis, resection of >50% of the circumference was strongly associated with stricture formation (odds ratio [OR] 4.17; 95% confidence interval [CI], 1.27-13.7). A 25-pack-year or greater history of tobacco use also trended toward stricture formation (OR 3.33; 95% CI, 0.929-12.1). Limitations: Retrospective design, sample size. Conclusion: Resection of at least 50% of the esophageal mucosal circumference is strongly associated with stricture formation. Patients with strong histories of tobacco use also may be more likely to develop esophageal strictures following EMR. (Gastrointest Endosc 2011;74:753-60.)
引用
收藏
页码:753 / 760
页数:8
相关论文
共 50 条
  • [21] Endoscopic Treatment for Barrett’s Esophagus and Early Esophageal Cancer
    Kenneth K. Wang
    Journal of Gastrointestinal Surgery, 2010, 14 : 946 - 947
  • [22] Endoscopic Therapy for Barrett's Esophagus and Early Esophageal Adenocarcinoma
    Leggett, Cadman L.
    Gorospe, Emmanuel C.
    Wang, Kenneth K.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2013, 42 (01) : 175 - +
  • [23] Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma
    Wolfsen, HC
    Hemminger, LL
    Raimondo, M
    Woodward, TA
    SOUTHERN MEDICAL JOURNAL, 2004, 97 (09) : 827 - 830
  • [24] Approaches for stricture prevention after esophageal endoscopic resection
    Abe, Seiichiro
    Iyer, Prasad G.
    Oda, Ichiro
    Kanai, Nobuo
    Saito, Yutaka
    GASTROINTESTINAL ENDOSCOPY, 2017, 86 (05) : 779 - 791
  • [25] Argon Plasma Coagulation Versus Endoscopic Mucosal Resection in Patients with Dysplastic Barrett's Esophagus
    Boix, Jaume
    Lorenzo-Zuniga, Vicente
    de Vega, Vicente Moreno
    Planas, Ramon
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (08) : 1808 - 1809
  • [26] Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma
    Rouphael, Carol
    Anil Kumar, Mythri
    Sanaka, Madhusudhan R.
    Thota, Prashanthi N.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [27] Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barrett's esophagus
    Leung, Wesley D.
    Chennat, Jennifer
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (05) : 575 - 578
  • [28] Endoscopic Therapy of Neoplasia Related to Barrett's Esophagus and Endoscopic Palliation of Esophageal Cancer
    Vignesh, Shivakumar
    Hoffe, Sarah E.
    Meredith, Kenneth L.
    Shridhar, Ravi
    Almhanna, Khaldoun
    Gupta, Akshay K.
    CANCER CONTROL, 2013, 20 (02) : 117 - 129
  • [29] Laparoscopic transgastric esophageal mucosal resection: a treatment option for patients with high-grade dysplasia in Barrett's esophagus
    Frantzides, Constantine T.
    Daly, Shaun C.
    Frantzides, Alexander T.
    Manelis, Thomas
    Marcinkevicius, Algis
    Luu, Minh B.
    AMERICAN JOURNAL OF SURGERY, 2016, 211 (03): : 534 - 536
  • [30] Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus
    Dunbar, Kerry B.
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 446 - 453